Allied Journal of Medical Research

All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.
Reach Us +1 (202) 780-3397

Commentary - Allied Journal of Medical Research (2022) Volume 6, Issue 1

Use of digital rheumatology in the current times of Covid-19.

 Tyler Slevin*

Department of Medicine, Orel State Medical University, Oryol Oblast, Russia

*Corresponding Author:
Tyler Slevin
Department of Medicine
Orel State Medical University
Oryol Oblast, Russia

Received: 01-Jan-2022, Manuscript No. AAAJMR-22-101; Editor assigned: 05-Jan-2022, PreQC No. AAAJMR-22-101(PQ); Reviewed: 19-Jan-2022, QC No AAAJMR-22-101; Revised: 24-Jan-2022, Manuscript No. AAAJMR-22-101(R); Published: 31-Jan-2022, DOI:10.35841/aaajmr-6.1.101

Citation: Slevin T. Use of digital rheumatology in the current times of Covid-19. Allied J Med Res. 2022; 6(1): 101

Visit for more related articles at Allied Journal of Medical Research



Digitalisation is changing medication, both for patients and doctors. Portable wellbeing including applications, telemedicine and man-made reasoning are entering the field quickly. This cycle is encouraged by the current pandemic, clearly requiring more independence and adaptability of patients and specialists. Computerized change in medical care eminently influences patients with persistent issues and long, interdisciplinary patient excursions. In rheumatology, most invulnerable intervened, degenerative or persistent torment problems are on-going. Hence our patients probably will reach out to computerized arrangements and ideally there will be superior patient consideration [1].

This assortment is committed to the subject Digital Rheumatology. The point of this series is to gather articles on new computerized apparatuses and arrangements and to portray their pragmatic use and execution in rheumatic patient consideration [2].

A profound gaining strategy for anticipating knee osteoarthritis radiographic movement from MRI. The ID of patients with knee osteoarthritis (OA) liable to advance quickly as far as design is basic to work with the improvement of illness changing medications.

Rheumatic and outer muscle sicknesses (RMDs) are perplexing persistent conditions that require standard observing and therapy. When a RMD has been analysed, standard infection adhere to up is essential. This incorporates the appraisal of treatment reaction, side effect following, blood tests, checking for unfriendly occasions and re-assessment of treatment signs. The COVID-19 pandemic presents an uncommon test to general wellbeing by and large, and, specifically, being taken care of by the persistently sick patients. Toward the start of the COVID-19 pandemic, serious changes and cuts in rheumatologic care were made. Due to pandemic regulation estimations, numerous patient arrangements must be cancelled3 or were changed over to phone or video consultations [3].

A large number accept that telemedicine holds incredible potential for the administration of RMDs. Digitalisation presently influences 90% of the medical care framework and has as of now prompted many changes for the two patients and specialists, urgently affecting the patient-specialist relationship. It has as of now been shown that rheumatology patients will utilize versatile wellbeing advances to further develop their infection status and to follow manifestations and illness activity. Also, the utilization of computerized wellbeing applications (DHAs) by rheumatologists has expanded over the past years. Even however studies exhibiting beneficial outcomes of uses ('applications') in the area of rheumatology are still lacking, the course of DHA execution in routine medical care is relied upon to be additionally sped up by the presentation of the Digital Health Care Act, which gives every one of those with legal health care coverage in Germany the repayment for specific DHAs.

For the effective turn of events and execution of telemedical ideas for the administration of RMDs, both the patient's and the rheumatologist's point of view are crucial. The primary inquiry is if and the way in which satisfactory therapy can occur carefully later on. This overview resolved this inquiry by analyzing the use and impression of computerized wellbeing applications, (for example, video counsels, clinical applications, advanced arrangements, journals, polls, online courses or the utilization of manifestation checkers) by RMD patients and rheumatologists in Germany. Specifically, changes as to these angles during the COVID-19 pandemic were recorded [4].


The rise of COVID-19 prompted uncommon changes to rheumatology clinical practice around the world, including the rebuilding of emergency clinics and the quick progress to virtual care. Changes that would have required a long time of arranging, pilot testing, and instruction were acted in 1 or 2 weeks.5 In our review, because of COVID-19, in-person practice diminished from 27 hours out of every week preceding the pandemic, to 10 hours out of each week during the pandemic.

Rheumatology short term offices and clinic benefits likewise went to virtual consideration during the pandemic. As a standard, patients were prescribed not to go to up close and personal visits in the event that they had any side effects of COVID-19. Variations included evaluating for COVID-19 manifestations, veil wearing, physical separating in sitting areas, hand cleanliness, and the utilization of proper PPE.


  1. Mehta B, Jannat-Khah D, Fontana MA, et al. Impact of COVID-19 on vulnerable patients with rheumatic disease: results of a worldwide survey. Rmd Open. 2020;6(3):e001378.
  2. Indexed at, Google scholar, Cross Ref

  3. Freudenberg S, Vossen D. Auswirkungen von. COVID-19 auf die rheumatologische Versorgung. Z Rheumatol. 2020;79(6):584-9.
  4. Indexed at, Google scholar Cross Ref

  5. Dejaco C, Alunno A, Bijlsma JW, et al. Influence of COVID-19 pandemic on decisions for the management of people with inflammatory rheumatic and musculoskeletal diseases: a survey among EULAR countries. Ann Rheum Dis. 2021;80(4):518-26.
  6. Indexed at, Google scholar, Cross Ref

  7. Perniola S, Alivernini S, Varriano V, et al. Telemedicine will not keep us apart in COVID-19 pandemic. Ann Rheum Dis. 2021;80(4):e48.
  8. Indexed at, Google scholar, Cross Ref

Get the App